BRCA2 and cancer: Thus, abnormally high replication rates caused by β-catenin accumulation in BRCA2-deficient cells are likely to represent a major source of DNA damage and an important contributing factor to the synergistic effect of oncogene activation and BRCA1/2 abrogation on suppressing cancer cell viability.